tiprankstipranks
ARS Pharmaceuticals (SPRY)
NASDAQ:SPRY
US Market
SPRY
ARS Pharmaceuticals
RESEARCH TOOLSreports
Want to see SPRY full AI Analyst Report?

ARS Pharmaceuticals (SPRY) Revenue

589 Followers
StatisticsMarket CapRevenue

ARS Pharmaceuticals Revenue

ARS Pharmaceuticals had a revenue of 33.66M in the quarter ending Jun 30, 2026, with 48.40%. This bring the company's revenue in the last twelve months to 116.93M, Decreased 18.12%. In the fiscal year ending Dec 31, 2025, ARS Pharmaceuticals had annual revenue of 84.28M with -5.46% growth.
Revenue (ttm)
116.93M
Revenue Growth
4.08%
P/S Ratio
6.17
Revenue/Employee
$432,195
Employees
195
Market Cap
$520.11M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
84.28M-4.87M-5.46%
Dec 31, 2024
89.15M89.12M+297,063.33%
Dec 31, 2023
30.00K-1.29M-97.72%
Dec 31, 2022
1.32M-4.19M-76.10%
Mar 31, 2022
5.51M-12.33M-69.13%
Dec 31, 2020
17.84M―+∞%
Dec 31, 2019
―――
Dec 31, 2018
―――